India's Glenmark to conduct trials for potential COVID-19 drug, shares jump

India's Glenmark to conduct trials for potential COVID-19 drug, shares jump
Reuters: Health
Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.


No comments:

Post a Comment